纳入跨性别和非二进制参与者在临床药物试验的第一阶段:当前的知识差距和考虑
Lauren E Walker1,2, Michael Stackpoole2, Daryl Hodge1
1Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.
British journal of clinical pharmacology
|May 10, 2024
概括
第1期临床试验需要多样化的志愿者. 目前的标准可能会排除跨性别和非二进制个体,影响药物安全和药物动力学研究. 包容性实践对于公平的医学进步至关重要.
科学领域:
- 临床药理学 临床药理学
- 卫生公平性健康公平性
- 跨性别者健康问题
背景情况:
- 第1期临床试验对于评估新药安全性和药理动力学至关重要.
- 健康的志愿者对于这些早期药物开发研究至关重要.
- 当前的参与者选择标准可能无意中将跨性别和非二进制个体排除在外.
研究的目的:
- 确定关于将跨性别和非二进制个体纳入第一阶段临床试验的知识差距.
- 讨论在早期药物开发中安全有效地纳入不同人群的考虑因素.
- 倡导研究性别肯定激素治疗对药物药理动学的影响.
主要方法:
- 在临床试验第一阶段招募当前实践的文献综述.
- 对现有的健康定义和对潜在偏差的选择标准的分析.
- 确定需要对跨性别和非二进制参与者进行进一步研究的领域.
主要成果:
- 当前的选择标准和健康定义往往不适应跨性别和非二进制个体的独特生理特征.
- 缺乏关于性别肯定激素治疗如何影响药物药理动力学的研究.
- 现有的生物参考范围可能不适合所有参与者.
结论:
- 包容性实践是必要的,以确保公平参与第一阶段临床试验.
- 需要进一步的研究来了解性别肯定激素治疗的药理动力学影响.
- 开发包容性的生物参考范围对于在不同人群中进行准确的健康评估至关重要.
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K


